Fran Rawlins retweeted
📣The £42M TRANSFORM study will get a £20M boost so that all eligible Black men are invited to join stage 2
📶Policies on healthcare for any group to be based on evidence
🇬🇧Govt also funding wider access to focal prostate therapy to ⬇️ harms of surgery & radiotherapy
TRANSFORM study extends prostate cancer screening to Black men in the UK
S&C's @LondonProstate1 welcomes the news that all eligible Black men in the UK will be offered prostate cancer screening as part of the landmark TRANSFORM study ⬇️
imperial.ac.uk/news/articles…
Fran Rawlins retweeted
📣The £42M TRANSFORM study will get a £20M boost so that all eligible Black men are invited to join stage 2
📶Policies on healthcare for any group to be based on evidence
🇬🇧Govt also funding wider access to focal prostate therapy to ⬇️ harms of surgery & radiotherapy
We're expanding research, widening treatment options and tackling inequalities in prostate cancer care.
✅ All eligible Black men will be invited to join a landmark screening trial.
✅ A targeted NHS screening programme will also be rolled out.
More: gov.uk/government/news/major…
Fran Rawlins retweeted
We had an amazing day at the London Landmarks Half Marathon yesterday! 🏃🏽♀️🏃🏽♂️
The @IP_London Run Club was proud to support @prost8uk!
We’re so close to our fundraising goal - help us get over the line!: justgiving.com/team/imperial…
Thank you for all the support! ❤️💙
Fran Rawlins retweeted
Meanwhile! Back at in London, @Fran_Rawlins gave a brilliant presentation showcasing TRANSFORM at the @ImperialCTU Unit Meeting 2025 #prostatecancer #prostatescreening
@ImperialSandC @ProstateUK @LondonProstate1
Fran Rawlins retweeted
The trial is led by researchers @ImperialNHS and @imperialcollege with @ucl, @QMUL and @ICR_London.
Backed by @ProstateUK, it is the biggest and most ambitious prostate cancer trial in 20 years that aims to transform diagnosis and reduce prostate cancer deaths by up to 40%.
2/2
Fran Rawlins retweeted
Prostate cancer is now the most commonly diagnosed cancer in England according to an analysis by @ProstateUK.
This #WorldCancerDay, we want to shine a light on the TRANSFORM trial which is looking to find the best way to screen for prostate cancer ➡️ imperial.nhs.uk/about-us/new…
1/2
Fran Rawlins retweeted
Fine balance of savings lives & harms of screening for prostate cancer
“…we have not shown enough risk mitigation yet to justify a national screening programme.”
Which is why @ProstateUK & @NIHRresearch funded £42M TRANSFORM study
thetimes.com/uk/healthcare/a…
Fran Rawlins retweeted
Congratulations #IP7PACIFIC - 8️⃣6️⃣5️⃣ patients recruited so far!
⏱️ Evaluating the role of biparametric MRI & image-fusion targeted biopsies to detect prostate cancer
🔗 imperial.ac.uk/news/233114/r…
#UrSoMe #prostatecancer #prostatecancerdiagnosis #bpMRI
Fran Rawlins retweeted
[7/7] Prostate Cancer UK are proud to have launched the £42m TRANSFORM trial to find the best way to screen for prostate cancer, so one day all men at risk are invited for regular tests to find aggressive prostate cancer in time for a cure.
prostatecanceruk.org/researc…
Fran Rawlins retweeted
It’s a complete disgrace. There has to be accountability. This is daily. Who is actually listening to this @thameswater @LondonPortAuth @LBC
📽️Footage just sent in of the Thames at Putney this morning‼️🤢
The Thames has been turned into a toxic soup of sewage - courtesy of @thameswater, complete regulatory failure and shameful inaction from government. 📷©@BritishRowing
@Feargal_Sharkey @SteveBackshall @jaowallace
Fran Rawlins retweeted
We're proud to announce that #OurImperial Professor Hashim Ahmed [@LondonProstate1] and Professor Rakesh Heer are two of the six lead researchers on @ProstateCancerUK's £42 million TRANSFORM screening trial.
TRANSFORM is the biggest and most ambitious prostate cancer trial in 20 years that aims to transform diagnosis and save thousands more lives each year.
imperial.ac.uk/news/253035/n…
Fran Rawlins retweeted
We are ✨incredibly proud✨ to be leading the #TRANSFORM prostate cancer screening trial in collaboration with our colleagues from @ucl @QMUL @ICR_London @royalmarsdenNHS @imperialcollege supported by @ProstateUK @NIHRresearch @MovemberUK
Fran Rawlins retweeted
Well done everyone. What a team! Very proud of every single one of them. #ipmasterclass24
And that’s it for #ipmasterclass24!
A big thank you from the @IP_London team to all our speakers, delegates, and industry 🙏
See you in 2025 for the next Imperial Prostate Masterclass jointly held with @FocalSociety!
Fran Rawlins retweeted
Thanks to our enthusiastic chairs @AJWLight and Mr Arnas Rakauskas.
Onto our final plenary session of Day 1: Prostate Biopsy, chaired by @johannboaz and @Fran_Rawlins.
Fran Rawlins retweeted
🧵@ImperialNHS has been awarded £3m by @NIHRresearch for a new HealthTech Research Centre, led by S&C's @profgeorgehanna, to support the development & evaluation of new diagnostic innovations for cancer, infectious & respiratory diseases, critical care, & primary and social care.
Fran Rawlins retweeted
🎉 What a fantastic way to end the year at the @ImperialSandC Awards!
Congratulations to everyone at @IP_London for their dedication and hard work in 2023!
@imperialurology @imperialcollege @ImperialNHS
Fran Rawlins retweeted
Fran Rawlins retweeted
🔬 Tomorrow (20/05) is #InternationalClinicalTrialsDay
🔬 Thank you to our hard working multi-disciplinary research team - and most importantly our patient participants!
🔬 Take a look at #ImperialProstate clinical trials past & present @ imperialprostate.org/clinica…
Fran Rawlins retweeted
Great milestone! This RCT will answer the key question of mpMRI vs bpMRI for prostate cancer detection
@LondonProstate1 @ProfPadhani @andrea_rockall @Heer_Lab
I hear at 30 now!
Whilst paired cohort studies might show non-inferiority, how will radiologists score, and urologists use, a biparametric MRI when that’s all they have?
#IP7PACIFIC is the only pivotal non-inferiority RCT of bpMRI vs. mpMRI
Fran Rawlins retweeted
I hear at 30 now!
Whilst paired cohort studies might show non-inferiority, how will radiologists score, and urologists use, a biparametric MRI when that’s all they have?
#IP7PACIFIC is the only pivotal non-inferiority RCT of bpMRI vs. mpMRI
🎉 Congratulations #IP7PACIFIC - 2️⃣5️⃣ patients recruited!
⏱️ Evaluating the role of biparametric MRI & image-fusion targeted biopsies to detect prostate cancer
🔗 imperial.ac.uk/news/233114/r…
@LondonProstate1 @Fran_Rawlins @imperialurology @CR_UK @SU2CUK #UrSoMe #prostatecancer





























